BBIO BridgeBio Pharma Inc

William Blair reit'd $BBIO OP/said While the focus has been on Attruby, the company is poised to launch three additional products over the next year and sees an additional $4 billion in de-risked peak sales opportunity across the three. $ALNY $PFE BAYRY NPPNY SRPT William Blair added We continue to believe these clinically de-risked opportunities are being overlooked by the Street and that shares are undervalued for the top-line growth profile and view BridgeBio as becoming a core smid-cap biotech holding. We reiterate our Outperform rating.

Jefferies reiterated $BBIO Buy-$110 ~Has >90% in Full Approval—says its $1B+ Peak Sales Seem Conservative. $BAYRY $NPPNY SRPT ALNY PFE Jefferies said in its notez: New Phase III analyses support BBP-418's (oral substrate) disease-modifying potential in LGMD21/R9 (a rare muscle disease), reinforcing our 90%+ conviction in a full approval by its Nov 27, 2026 PDUFA. In short, '418 shows troponin/LVEF cardiac benefits, building on prior (+) findings across biomarkers and function (e.g. 100MTT, FVC). Net-net, our $1B+ peak sales seem conservative, since '418 has pot'l pricing power and is expanding into LGMD2M/2U and Fukuyama.

$BBIO BridgeBio Announces FDA Acceptance And Priority Review Of NDA For Oral Infigratinib For Children With Achondroplasi The FDA set a PDUFA target action date of February 4, 2027. If approved, infigratinib would be the first oral therapy for achondroplasia. In the Phase 3 PROPEL 3 trial it showed a mean height-velocity gain of +2.10 cm a year over placebo (p<0.0001).

$BBIO Still on track to become a significant bio player. The next 18 months should be a wild ride.

$BBIO In the Aug 10th press release that announced Q2 earnings there was a note "BridgeBio will host a Commercial Day in New York City on October 8, 2026, to discuss commercial readiness and launch strategy across its three upcoming launches" Does anyone know if this is still happening and will they webcast this event. I can't find a link anywhere.

$BBIO Bullish Harami Candlestick Pattern Formed at Downtrend. Wait for the confirmation from the next day's candle. Bullish Harami is a two-candle reversal pattern where a small bullish candle forms within the body of a larger bearish candle, indicating a possible bullish reversal.